Skip main navigation
×

You do not have any saved searches

  • Genotype-Dependent Impairment of Hemoglobin Clearance Increases Oxidative and Inflammatory Response in Human Diabetic Atherosclerosis

  • Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

  • Abstract 3866: Predictors of Coronary Atherosclerosis Differ Between Patients with and without Chronic Kidney Disease

  • Abstract 5015: Thrombolysis in Myocardial Infarction (TIMI) Risk Score and Mortality in Patients with Advanced Chronic Kidney Disease (CKD) and on Dialysis

  • Abstract 1571: Association of Chronic Kidney Disease With Atrial Fibrillation in the United States

  • Abstract 20850: Impact of Self-Reported Ethnicity on Response to Clopidogrel in Patients Underoing Percutaneous Coronary Intervention

  • Abstract 20886: Impact of Pre-Dialysis Chronic Kidney Disease on Response to Clopidogrel in Patients Undergoing Coronary Angiography

  • Abstract 11314: Inverse Relationship Between Body Mass Index and Coronary Artery Calcification in Older Patients with Clinically Significant Coronary Lesions

  • Abstract 13371: Frequency and Clinical Impact of Nuisance Bleeding Among Patients Receiving Aspirin and Clopidogrel: Insights from the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial

  • Abstract 15180: Impact of the Everolimus-Eluting Stent on Stent Thrombosis According to Baseline Risk of Study Population

  • Abstract 15919: Impact of Bivalirudin Therapy on Mortality in Patients With High Risk Features Undergoing PCI: A Patient-Level Pooled Analysis From the REPLACE-2, ACUITY and HORIZONS-AMI Trials

  • Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS

  • Abstract 17291: Impact of Diabetes Mellitus on Atherosclerotic Plaque Lipid Regression: Results from the Prospective, Randomized YELLOW Trial

  • Abstract 18379: Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV trials

  • Abstract 18402: Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding After PCI: Results from the PARIS Registry

  • Abstract 18591: Anatomically- Versus Clinically-derived Risk Scores Have Markedly Differing Predictive Abilities Following PCI For Multivessel CAD: The “TLR Paradox”

  • Abstract 18677: The ACEF Risk Score Exhibits Superior Predictive Ability for Adverse Clinical Outcomes in Women Undergoing PCI

  • Abstract 18793: Impact of Chronic Kidney Disease on Outcomes in Patients Undergoing Balloon Aortic Valvuloplasty: Results from the BRAVO Study

  • Abstract 19124: Detection and Prevalence of Systemic Atherosclerosis: Results from the High-Risk Plaque (HRP) Initiative

  • Abstract 19161: Pregnancy-Induced Disorders Identify High-Risk Women who Benefit from Cardiovascular Screening: Results from the Women's Heart Health Initiative, an OB/GYN Screening Pilot Program